Venquis Therapeutics

Venquis Therapeutics is a biotechnology startup founded in 2021, with a focus on chemically targeted protein degradation. Their slogan, "Chemically Targeted Protein Degradation," encapsulates their approach, which involves utilizing powerful chemical screens to develop new classes of small molecule drugs specifically targeting mutant proteins. Their aim is to harness the power of protein degradation to address challenges in oncology and degenerative diseases. The company prides itself on an experienced team adept in both drug discovery and platform development within the biotechnology, health care, and life sciences industries. As of now, there is no available information regarding their headquarters, last investment, or the investors involved.